This article has a correction
Please see: Sentinel node biopsy for malignant melanoma
Having this biopsy gives psychological benefits
- S S Rayatt (sukhr@hotmail.com), specialist registrar in plastic surgery,
- S P Hettiaratchy, specialist registrar in plastic surgery
- Department of Plastic Surgery, Sandwell Healthcare NHS Trust, West Bromwich, West Midlands B71 4HJ
- Department of Plastic Surgery, Selly Oak Hospital, Birmingham B29 6JD
- West Bar Surgery, Banbury OX16 9SF
- Melanoma Unit, St George's Hospital, London SW17 0QT
- Department of Plastic and Reconstructive Surgery, Radcliffe Infirmary, Oxford OX2 6HE
- St John's Institute of Dermatology, St Thomas's Hospital, London SE1 7EH
- St Thomas's Hospital, London SE1 7EH
- Royal Free Hospital, London NW3 2PF
- Department of Dermatology, Hammersmith Hospital, London W12 0NN
- Melanoma and Sarcoma Unit, Royal Marsden Hospital, London SW3 6JJ
EDITOR—The editorial by Thomas and Patocskai summarises the current state of sentinel lymph node biopsy for malignant melanoma.1 What the authors omitted to address was patients' perception of the procedure.
Anecdotal evidence suggests that patients with melanoma derive psychological benefit from having the procedure, regardless of the result. To investigate any such benefit our unit carried out a study looking at the acceptability and benefits of the procedure. A specially designed questionnaire was sent to 110 patients who had undergone the procedure between August 1997 and February 1999.
Ninety eight patients (89%) replied, including all those in whom the result had been positive (19/110). To study any time dependent trends the respondents were subdivided into three subgroups, depending on length of follow up (table). Most patients (95/98) were glad that they had had the procedure, though the effects decreased with time (table). Overall 89 of the patients believed that they had gained some benefit from the biopsy, and 96 said that they would recommend it to other patients.
- In this window
- In a new window
Benefits of sentinel node biopsy to 98 patients with malignant melanoma. Values are numbers (percentages) of patients
Most patients with melanoma undoubtedly derive at least short term psychological benefits from having a sentinel lymph node biopsy. This effect seems to be independent of the result of the biopsy itself. The decreased reassurance with time may simply represent a time dependent factor but might be due to the frequent clinic visits and additional biopsies of suspicious lesions, which cause increased anxiety in patients with melanoma.2
The procedure has high patient acceptability and offers patients a proactive option in addition to regular clinic reviews after initial diagnosis. It does not, however, seem greatly to influence patients' worries about being “cured” or fully enable patients to plan for the future. The small psychological …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: How much of a social media profile can doctors have?
Published 13 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 13 February 2012
Re: Is it unethical for doctors to encourage healthy adults to donate a kidney to a stranger? No
Published 13 February 2012
Re: Report predicts 20 million AIDS orphans in Africa by 2010
Published 13 February 2012
Re: On the impossibility of being expert
Published 13 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012